论文信息 - Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial) - 字舞流文

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

K. Akashi | T. Miyamoto | M. Hino | J. Kuroda | I. Matsumura | J. Ishikawa | Y. Kanakura | T. Kawaguchi | H. Shibayama | K. Matsuoka | T. Kamimura | C. Hirase | H. Nakamae | T. Shimose